triazolam has been researched along with l 655,708 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cook, JM; Dayer, CA; He, X; Huang, Q; Liu, R; Ma, C; McKernan, R; Wenger, GR; Yu, S | 1 |
| Bracher, F; Fedorov, O; Filippakopoulos, P; Keller, M; Knapp, S; Morgenstern, O; Picaud, S; Wrobel, M | 1 |
2 other study(ies) available for triazolam and l 655,708
| Article | Year |
|---|---|
Pharmacophore/receptor models for GABA(A)/BzR subtypes (alpha1beta3gamma2, alpha5beta3gamma2, and alpha6beta3gamma2) via a comprehensive ligand-mapping approach.
Topics: Animals; Benzodiazepines; Carbolines; Cell Line; Columbidae; Conditioning, Operant; Crystallography, X-Ray; Humans; Indoles; Ligands; Male; Models, Molecular; Pyrimidines; Quinolones; Radioligand Assay; Receptors, GABA-A; Saimiri; Stereoisomerism; Structure-Activity Relationship | 2000 |
Benzodiazepines and benzotriazepines as protein interaction inhibitors targeting bromodomains of the BET family.
Topics: Alprazolam; Benzazepines; Benzodiazepines; Cell Cycle Proteins; GABA Modulators; Humans; Midazolam; Models, Molecular; Nuclear Proteins; Protein Interaction Maps; Protein Structure, Tertiary; Transcription Factors | 2012 |